1-(2,3-Dihydro-6-methyl-1H-pyrrolizin-5-yl)-1,4-pentanedione

Metabolite details

Identifier

NLJUZIDVCBWHAK-UHFFFAOYSA-N

InChI Key

NLJUZIDVCBWHAK-UHFFFAOYSA-N

IUPAC name

1-(2-methyl-6,7-dihydro-5H-pyrrolizin-3-yl)pentane-1,4-dione

Preferred name

1-(2,3-Dihydro-6-methyl-1H-pyrrolizin-5-yl)-1,4-pentanedione

INN name

—

Synonym

—

ChEBI

CHEBI:179205

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Transcriptional memory of dFOXO activation in youth curtails later-life mortality
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• Transcriptomic and lipidomic profiling of subcutaneous and visceral adipose tissues in 15 vertebrates

Observed in differential profiles

• Wild_type_vs_hfq
• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• RU-_Control_vs_RU+_Switch
• Control_vs_ZYP_High_Dose
• Male_19_days_vs_Male_1_day
• G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT